Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for BDX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 1981. Start Trial.
Date Value
September 30, 2025 3.43B
September 30, 2024 3.798B
September 30, 2023 2.989B
September 30, 2022 2.634B
September 30, 2021 4.647B
September 30, 2020 3.539B
September 30, 2019 3.33B
September 30, 2018 2.865B
September 30, 2017 2.55B
September 30, 2016 2.559B
September 30, 2015 1.73B
September 30, 2014 1.746B
September 30, 2013 1.717B
September 30, 2012 1.693B
September 30, 2011 1.638B
September 30, 2010 1.659B
September 30, 2009 1.692B
September 30, 2008 1.688B
September 30, 2007 1.236B
September 30, 2006 1.104B
September 30, 2005 1.216B
September 30, 2004 1.100B
September 30, 2003 905.70M
Date Value
September 30, 2002 836.03M
September 30, 2001 778.64M
September 30, 2000 615.49M
September 30, 1999 431.79M
September 30, 1998 500.76M
September 30, 1997 442.75M
September 30, 1996 460.44M
September 30, 1995 472.20M
September 30, 1994 479.55M
September 30, 1993 319.84M
September 30, 1992 308.25M
September 30, 1991 254.07M
September 30, 1990 258.96M
September 30, 1989 146.94M
September 30, 1988 202.36M
September 30, 1987 138.20M
September 30, 1986 75.27M
September 30, 1985 124.82M
September 30, 1984 209.30M
September 30, 1983 168.08M
September 30, 1982 87.16M
September 30, 1981 124.15M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Abbott Laboratories 9.566B
Boston Scientific Corp. 4.534B
Stryker Corp. 5.044B
Baxter International, Inc. 845.00M
DexCom, Inc. 1.441B